Alnylam Pharmaceuticals (ALNY) Net Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,849.00 |
| Dec 31, 2025 | 2,429.00 |
| Sep 30, 2025 | 4,571.00 |
| Jun 30, 2025 | -601.00 |
| Mar 31, 2025 | -4,750.00 |
| Dec 31, 2024 | 1,723.00 |
| Sep 30, 2024 | -4,196.00 |
| Jun 30, 2024 | 8,404.00 |
| Mar 31, 2024 | 4,119.00 |
| Dec 31, 2023 | 3,058.00 |
| Sep 30, 2023 | 17,327.00 |
| Jun 30, 2023 | 3,679.00 |
| Mar 31, 2023 | 5,817.00 |
| Dec 31, 2022 | 3,804.00 |
| Sep 30, 2022 | -4,458.00 |
| Jun 30, 2022 | -3,744.00 |
| Mar 31, 2022 | 10.00 |
| Dec 31, 2021 | 4,893.00 |
| Sep 30, 2021 | 9,226.00 |
| Jun 30, 2021 | 8,645.00 |
| Mar 31, 2021 | 7,038.00 |
| Dec 31, 2020 | 23,640.00 |
| Sep 30, 2020 | 9,639.00 |
| Jun 30, 2020 | 31,846.00 |
| Mar 31, 2020 | 36,321.00 |
| Dec 31, 2019 | 61,998.00 |
| Sep 30, 2019 | 1.16 Mn |
| Jun 30, 2019 | 5,604.00 |
| Mar 31, 2019 | 9,845.00 |
| Dec 31, 2018 | -63,025.00 |
| Sep 30, 2018 | -1.11 Mn |
| Jun 30, 2018 | 19,639.00 |
| Mar 31, 2018 | -7,897.00 |
| Dec 31, 2017 | 27,373.00 |
| Sep 30, 2017 | 4,621.00 |
| Jun 30, 2017 | 29,161.00 |
| Mar 31, 2017 | 83,608.00 |
| Dec 31, 2016 | 55,269.00 |
| Sep 30, 2016 | 44,899.00 |
| Jun 30, 2016 | -21,334.00 |
| Mar 31, 2016 | -112,571.00 |
| Dec 31, 2015 | -102,042.00 |
| Sep 30, 2015 | -81,398.00 |
| Jun 30, 2015 | -21,307.00 |
| Mar 31, 2015 | 297,225.00 |
| Dec 31, 2014 | 11,728.00 |
| Sep 30, 2014 | -7,014.00 |
| Jun 30, 2014 | -39,933.00 |
| Mar 31, 2014 | -320,015.00 |
| Dec 31, 2013 | -81,202.00 |
| Sep 30, 2013 | -21,381.00 |
| Jun 30, 2013 | -14,711.00 |
| Mar 31, 2013 | 687.00 |
| Dec 31, 2012 | 30,263.00 |
| Sep 30, 2012 | -5,270.00 |
| Jun 30, 2012 | 502.00 |
| Mar 31, 2012 | 2,271.00 |
| Dec 31, 2011 | 24,379.00 |
| Sep 30, 2011 | -2,886.00 |
| Jun 30, 2011 | -1,209.00 |
| Mar 31, 2011 | -2,776.00 |
| Dec 31, 2010 | -344.00 |
| Sep 30, 2010 | 317.00 |
| Jun 30, 2010 | 3,731.00 |